Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6‐week scan: association with chromosomal defects and reproducibility of the method

8 Mar 2006

Abstract excerpt

OBJECTIVE: To determine the reproducibility of diagnosing tricuspid regurgitation (TR) at 11 + 0 to 13 + 6 weeks' gestation, to examine further the relationship between TR and the presence of chromosomal defects and to calculate the likelihood ratios for trisomy 21 and trisomy 18 in fetuses with TR. METHODS: Pulsed wave Doppler of flow across the tricuspid valve was carried out by 12 obstetricians, trained in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Valve Diseases and Treatments
Share to Congenital Heart Disease Studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16526003
DOI: 10.1002/uog.2736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6‐week scan: association with chromosomal defects and reproducibility of the methodPMID 16526003Read ↗

Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11–14 weeks of gestationSemantic proximity Read ↗

Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestationSemantic proximity Read ↗

Trisomy 21: 91% detection rate using second‐trimester ultrasound markersSemantic proximity Read ↗

Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestationSemantic proximity Read ↗

Early detection of fetal cardiac abnormalities: how effective is it and how should we manage these patients?Semantic proximity Read ↗

Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flowSemantic proximity Read ↗

Prevalence of increased nuchal translucency in fetuses with congenital cardiac disease and a normal karyotypeSemantic proximity Read ↗

Prenatal diagnosis of congenital heart diseaseSemantic proximity Read ↗

Prenatally detectable congenital heart defects in fetuses with Down syndromeSemantic proximity Read ↗

Nuchal translucency and major congenital heart defects in fetuses with normal karyotype: a meta‐analysisSemantic proximity Read ↗

Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10–14 weeks of gestationSemantic proximity Read ↗

Fetal echocardiography as a predictor of chromosomal abnormalitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.